Close
Mittul Mehta, Tevogen's Chief Information Officer and Head of Tevogen.AI, highlighted the transformative potential of Tevogen Bio's innovative T cell technology at the Longwood Spring MIT Conference. Mehta discussed the company's bold strategy to revolutionize T cell therapies and shape the future of healthcare. Tevogen's focus on cutting-edge technology and research aims to bring groundbreaking advancements to the field of immunotherapy.
The conference provided a platform for Tevogen.AI to showcase its advancements in T cell therapies and its commitment to innovation. Mehta's insights shed light on the company's vision to drive progress in personalized medicine and cancer treatment. Tevogen's presence at the prestigious MIT event signifies its leadership in the biotechnology sector and dedication to improving patient outcomes.
Insider Monkey on MSN.com 11month
FOX News on MSN.com 8month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
